Importantly, the tumor antigen peptide-MHC complex and costimulatory factors, such as CD86, are expressed at high levels on the surface of mature DC-derived EVs, which can be presented to immune cells to activate TAA-specific effector T cells (80, 81). This evidence concerns the gene CD86 and neoplasm.